Abbott Seeks UK Ban On Chinese Rival's Glucose Monitors
Abbott has launched another case in England against medical device maker Sibionics, accusing the Chinese group of infringing its patent by selling rival glucose monitoring systems and escalating the companies' global...To view the full article, register now.
Already a subscriber? Click here to view full article